• Myriocin Reverses dAGE-Induced Metabolic Dysfunction in Mice

  2026-05-25

  This study demonstrates that myriocin, a serine palmitoyltransferase inhibitor, restores metabolic homeostasis in mice exposed to high dietary advanced glycation end products (dAGEs) by activating AMPK-PGC1α signaling and improving lipid and glucose metabolism. The findings highlight a novel mechanism for combating dAGE-induced obesity and suggest new experimental avenues for sphingolipid metabolism research.

• Deep Learning of USC Mitochondria for Alzheimer’s Biomarkers

  2026-05-25

  This study pioneers an AI-based framework that analyzes mitochondrial morphology in urine-derived stem cells (USCs) as a non-invasive biomarker for Alzheimer’s disease. The approach offers dynamic, patient-specific insights into mitochondrial dysfunction, a core component of AD pathology, and demonstrates robust discrimination between cognitively impaired and healthy individuals.

• Decoding Redox Dynamics: Advanced ROS Assay Kit (DHE) Strate

  2026-05-24

  Explore how the Reactive Oxygen Species Assay Kit with dihydroethidium (DHE) probe enables precise, quantitative insight into cellular oxidative stress. This article delivers a mechanistic and translational perspective, uniquely integrating redox pathway research with assay optimization.

• Aminopeptidase Inhibition in Malaria: Phebestin’s Antiplasmo

  2026-05-23

  This study introduces phebestin, a bestatin-related aminopeptidase inhibitor, as a potent agent targeting Plasmodium falciparum with nanomolar efficacy. The findings clarify the essential role of metalloaminopeptidases in malaria parasites and suggest new therapeutic strategies leveraging aminopeptidase inhibition.

• Ciprofloxacin in Antimicrobial Resistance Research Workflows

  2026-05-22

  Ciprofloxacin, a benchmark fluoroquinolone antibiotic, empowers advanced studies on DNA replication inhibition and multidrug resistance in bacterial models. This article translates the latest epidemiological findings and practical lab experience into robust protocols, troubleshooting strategies, and innovative applications for antimicrobial resistance research.

• Mechanisms of Cell Death in Heart Disease: Regulated Pathway

  2026-05-22

  The reference study establishes that both apoptosis and necrosis in cardiac tissue involve highly regulated and interconnected molecular pathways, challenging the traditional view of necrosis as a purely passive process. These insights inform new directions for therapeutic research targeting cell death, with implications for diseases such as myocardial infarction and heart failure.

• Screening FDA-Approved Drugs Reveals MERS-CoV Inhibitors in

  2026-05-21

  de Wilde et al. systematically screened an FDA-approved drug library and identified four small molecules that inhibit MERS-CoV replication in vitro at low micromolar concentrations. These findings offer a rapid translational path for repurposing existing drugs against emerging zoonotic coronaviruses, while highlighting the challenges and opportunities for antiviral drug discovery.

• Nanobody Targeting PstS-1: Advancing TB Granuloma Imaging

  2026-05-21

  Dhekale et al. have isolated and characterized a high-affinity nanobody (C8Nb) specific to the PstS-1 protein of Mycobacterium tuberculosis, a key antigen associated with TB granulomas. Their findings indicate that nanobody-based tools could improve molecular imaging and diagnostics, particularly for challenging cases of extrapulmonary or low-burden TB.

• Translational Leverage: Mechanistic Mastery with EZ Cap EGFP

  2026-05-20

  This thought-leadership article explores the mechanistic sophistication and translational opportunities of EZ Cap™ EGFP mRNA (5-moUTP), contextualizing its advantages in immune evasion, stability, and in vivo imaging. Integrating recent breakthroughs in organ-targeted mRNA delivery and macrophage-based repair, it delivers actionable guidance for researchers seeking reproducibility and impact in gene expression studies. The piece bridges mechanistic insight with strategic workflow recommendations, referencing both contemporary literature and APExBIO product intelligence.

• Pifithrin-α (PFTα) in Neuroprotection: Decoding p53 Inhibiti

  2026-05-20

  Explore how Pifithrin-α, a potent p53 inhibitor, advances neuroprotection by dissecting its unique action against p53-mediated ferroptosis. This article delivers a distinct translational outlook for researchers seeking to mitigate neurotoxic effects and optimize assay design.

• Technical Guide: HyperScribe™ T7 High Yield Cy3 RNA Labeling

  2026-05-19

  The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus enables efficient, randomly Cy3-labeled RNA probe synthesis for fluorescence-based detection in research workflows, including in situ hybridization and Northern blotting. It is not suitable for diagnostic, therapeutic, or clinical applications, and should be reserved strictly for research use.

• NBC19: Precision NLRP3 Inhibition for Inflammation & Metasta

  2026-05-19

  Explore how NBC19, a nanomolar NLRP3 inflammasome inhibitor from APExBIO, is redefining inflammation research and translational strategies for targeting metastatic microenvironments. This thought-leadership article connects mechanistic insight on IL-1β regulation and inflammasome signaling with strategic guidance for researchers investigating the interplay between inflammation, tumor-derived macrophages, and metastatic niche formation.

• Strategic Redox Sensing: Dihydroethidium in Translational Bi

  2026-05-18

  This thought-leadership article explores how Dihydroethidium (DHE, hydroethidine) is revolutionizing superoxide detection and oxidative stress assays, with an emphasis on mechanistic insight and strategic guidance for translational researchers. Drawing on breakthroughs in pulmonary vascular remodeling and inflammation, we illustrate how DHE informs new frontiers in cardiovascular, metabolic, and apoptosis research. The piece uniquely bridges cutting-edge scientific findings with workflow optimization, highlighting APExBIO’s DHE as a high-purity, research-grade probe for robust intracellular ROS measurement, and providing actionable guidance for researchers navigating disease modeling and therapeutic development.

• Moxidectin Potentiates Polyene Antifungals via Ergosterol Mo

  2026-05-18

  This study demonstrates that moxidectin, a macrocyclic lactone anthelmintic, elevates ergosterol biosynthesis in Candida albicans, resulting in potent synergy with polyene antifungals against oral candidiasis. The findings introduce a mechanistically distinct approach for enhancing antifungal efficacy and offer a translational framework for drug repurposing in mycology.

• Cy5-UTP (Cyanine 5-UTP): Precision RNA Labeling for FISH & A

  2026-05-17

  Cy5-UTP (Cyanine 5-uridine triphosphate) is a validated fluorescent nucleotide analog enabling high-sensitivity RNA labeling via in vitro transcription. It supports robust RNA probe synthesis, facilitating direct detection in molecular biology applications such as FISH and dual-color expression arrays.

531 records 7/36 page Previous Next First page 上5页 678910 下5页 Last page